Search - tctmd.com

Displaying 1 - 20 of 82

Sort: Relevancy | Date

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

Shelley Wood

April 25, 2023

News Opinion CV Team Dispatch

January 2023 News Roundup

L.A. McKeown

January 16, 2023

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Yael L. Maxwell

July 13, 2021

News Daily News

Traditional Cath Lab Practices Scrutinized, Some Debunked, in AHA Statement

Todd Neale

July 05, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

Advertisement

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Aging, Angina, and Invasive Management: Some Nuance From ISCHEMIA

January 2023 News Roundup

April 2022 News Roundup

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

February 2022 News Roundup

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

November 2021 News Roundup

Women Stand to Gain the Most From Standardized STEMI Protocols

Tastes Like Ticagrelor: Mouth-Dissolving Pills Match Standard Ones in ACS

Traditional Cath Lab Practices Scrutinized, Some Debunked, in AHA Statement

April 2021 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content